Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation

被引：0
|
作者：
Nicolas -Xavier Bonne
Rabih Aboukais
Marc Baroncini
Audrey Hochart
Pierre Leblond
Franck Broly
Frédérique Dubrulle
Jean-Paul Lejeune
Christophe Vincent
机构：
[1] CHRU de Lille,Department of Otology and Neurotology
[2] CHRU de Lille,Department of Neurosurgery
[3] Centre Oscar Lambret,Department of Pediatric Oncology
[4] CHRU de Lille,Department of Genetic
[5] CHRU Lille,Service de Toxicologie, Génopathies
[6] CHRU Lille,Department of Radiology, Hôpital Huriez
来源：
Child's Nervous System | 2016年 / 32卷
关键词：
Neurofibromatosis type 2; Vestibular schwannoma; Middle fossa; Hearing préservation; Auditory brainstem implant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2403 / 2413
页数：10
相关论文
共 50 条
  • [41] Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
    Hochart, Audrey
    Gaillard, Vianney
    Baroncini, Marc
    Andre, Nicolas
    Vannier, Jean-Pierre
    Vinchon, Matthieu
    Dubrulle, Frederique
    Lejeune, Jean-Paul
    Vincent, Christophe
    Neve, Veronique
    Sudour Bonnange, Helene
    Bonne, Nicolas Xavier
    Leblond, Pierre
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (02) : 229 - 236
  • [42] Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
    Audrey Hochart
    Vianney Gaillard
    Marc Baroncini
    Nicolas André
    Jean-Pierre Vannier
    Matthieu Vinchon
    Frederique Dubrulle
    Jean-Paul Lejeune
    Christophe Vincent
    Véronique Nève
    Héléne Sudour Bonnange
    Nicolas Xavier Bonne
    Pierre Leblond
    Journal of Neuro-Oncology, 2015, 124 : 229 - 236
  • [43] Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
    Evan C. Cumpston
    Steven D. Rhodes
    Charles W. Yates
    Current Oncology Reports, 2023, 25 : 531 - 537
  • [44] Management Strategy of Vestibular Schwannoma in Neurofibromatosis Type 2
    Odat, Haitham Ahmad
    Piccirillo, Enrico
    Sequino, Giuliano
    Taibah, Abdelkader
    Sanna, Mario
    OTOLOGY & NEUROTOLOGY, 2011, 32 (07) : 1163 - 1170
  • [45] Hemifacial Spasm as Rare Clinical Presentation of Vestibular Schwannomas
    Liu, Jiang
    Liu, Peng
    Zuo, Ying
    Xu, Xiaoli
    Liu, Hongju
    Du, Rose
    Yu, Yanbing
    Yuan, Yue
    WORLD NEUROSURGERY, 2018, 116 : E889 - E894
  • [46] Neurofibromatosis Type 2: Presentation, Major Complications, and Management, With a Focus on the Pediatric Age Group
    Ardern-Holmes, Simone
    Fisher, Gemma
    North, Kathryn
    JOURNAL OF CHILD NEUROLOGY, 2017, 32 (01) : 9 - 22
  • [47] Hearing preservation in surgery for large vestibular schwannomas Clinical article
    Wanibuchi, Masahiko
    Fukushima, Takanori
    McElveen, John T., Jr.
    Friedman, Allan H.
    JOURNAL OF NEUROSURGERY, 2009, 111 (04) : 845 - 854
  • [48] Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2
    Kuo, Y. -H.
    Roos, D.
    Broph, B. P.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (07) : 744 - 748
  • [49] Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis
    Bardia Hajikarimloo
    Salem M. Tos
    Mohammadamin Sabbagh Alvani
    Alireza Kooshki
    Ibrahim Mohammadzadeh
    Mohammad Amin Habibi
    BMC Cancer, 25 (1)
  • [50] Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
    Karajannis, Matthias A.
    Legault, Genevieve
    Hagiwara, Mari
    Giancotti, Filippo G.
    Filatov, Alexander
    Derman, Anna
    Hochman, Tsivia
    Goldberg, Judith D.
    Vega, Emilio
    Wisoff, Jeffrey H.
    Golfinos, John G.
    Merkelson, Amanda
    Roland, J. Thomas
    Allen, Jeffrey C.
    NEURO-ONCOLOGY, 2014, 16 (02) : 292 - 297
12345